Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 28, 2022 at 08:44 pm IST
Share
Changjiang Runfa Health Industry Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 4,342.21 million compared to CNY 4,228.96 million a year ago. Revenue was CNY 4,369.82 million compared to CNY 4,240.58 million a year ago. Net loss was CNY 412.99 million compared to net income of CNY 247.69 million a year ago. Basic loss per share from continuing operations was CNY 0.3341 compared to basic earnings per share from continuing operations of CNY 0.2004 a year ago. Diluted loss per share from continuing operations was CNY 0.3341 compared to diluted earnings per share from continuing operations of CNY 0.2004 a year ago.
ChangjiangRunfa Health Industry Co., Ltd., formerly ChangjiangRunfa Medicine Co., Ltd., is a China-based company mainly engaged in the production and sale of pharmaceutical raw materials and preparations. The Company is principally engaged in research and development, production and sales of pharmaceutical raw materials and preparations, proprietary Chinese medicines and providing medical services, medical investment and investment in health industry businesses. The Company is also engaged in the research, development, manufacture, sale and service of elevator guide rail system components. The Companyâs products include solid guide rails, rough guide rails, hollow guide rails, accessories and automotive sections, channel steel products, as well as escalator guide rails and others. The Company offers its elevator guide rail products for elevator manufacturers, including Mitsubishi, Otis, KONE and Thyssen. The Company distributes its products in domestic markets and to overseas markets.